Recently, the China Health Promotion Association, sponsored by the health press and the Chinese National Health Association, supported by the Roche pharmaceutical company, "China's breast cancer scientific management promotion project" was launched in Beijing. The breast cancer breast cancer single disease management and standardization level of medical treatment is further enhanced. It ensures the quality and safety of breast cancer diagnosis and treatment, better protects the health rights and interests of patients, and gradually improves the five year survival rate of breast cancer patients. As the most effective and longest survival cancer in China, the diagnosis and treatment of breast cancer has entered the era of chronic disease management. Xu binghe, academician of the Chinese Academy of engineering, said: "Breast cancer has become a marker of cancer management. Under the background of implementing the strategy of healthy China, breast cancer is gradually changing from the multidisciplinary comprehensive diagnosis and treatment mode with disease as the core to the all-around, interdisciplinary management mode with patient centered. This requires us to take the life cycle health management as the core goal, and comprehensively promote the coverage of early cancer prevention and high-risk screening, multi-disciplinary standardized diagnosis and treatment, and chronic diseases. "Interdisciplinary management of 'all-round and whole cycle' health management of cancer associated diseases." Professor Wu Jiong, director of the breast cancer Specialized Committee of the China Cancer Association, said that as part of the systematic treatment of early breast cancer, neoadjuvant therapy not only provided the breast cancer patients with the possibility of breast conserving, but also provided information for the patient's drug sensitivity assessment, so as to guide subsequent treatment and allow more patients to get the chance of cure. "Breast cancer in China is now being standardized. The key points should be focused on neoadjuvant therapy, breast conserving surgery and late treatment. Only when these short boards are added, can breast cancer patients have more chances to heal physically and mentally and to have higher quality of life." Wu Jiong said. "Breast cancer scientific management promotion project" plan has covered 297 hospitals in 30 provinces in 1 years. The organizer will issue the executive Manual of breast cancer multidisciplinary center, and invite the national well-known experts to organize regional project initiation meeting and academic exchange meeting. Breast cancer surgery, internal medicine, pathology, imaging department, Department of Hematology and other disciplines will be carried out in all levels of hospitals to conduct standardized training of breast cancer, and guide the hospital to carry out standardized diagnosis and treatment. (outlook new era)